Hisense Ltd.

Therapeutic Area(s):
Company Status:
Revenue Growth

Company at a Glance

Hisense Ltd. is a privately held, medical device company active in development, manufacturing and marketing of health monitoring baby products. The company is active in detection and prevention of sudden infant death syndrome (SIDS) being the leading cause of death in basically healthy infants up to one year of age.
Company’s products meet the stringent requirements and needs of the institutional and private sectors and are used by parents and hospitals around the world.
Hisense Ltd. is present in over 30 countries through its subsidiaries and exclusive international distributors.
The Company is ISO 9001 and ISO 13485 (medical devices) approved company and is regularly audited by LNE (GMED), a European Notified Body, to support these approvals.
With over 24 years of experience in baby products and numerous successful patents, we constantly seek new ways to make parenting easier and safer.

Technology & Product(s)

Babysense is a highly sensitive non-touch baby Breathing Monitor intended for detection of respiratory distress and cessation (apnea) in infants. It constantly monitors baby’s breathing micro movements through the mattress during baby’s sleep and gives an alert to caretakers if breathing stops or becomes irregularly slow, giving critical time to intervene. A quick response can make the difference between something minor and a critical situation.
Babysense is the original and first-to-market monitor in its kind. Babysense was developed in view of the dangers that infants may face in hospitals and at homes associated with sudden infant death syndrome (commonly known as SIDS and Cot/Crib Death).
Babysense monitor is highly effective and has helped protecting over 1,000,000 babies from SIDS around the world. It provides a vital measure of protection, which, when combined with safe sleeping precautions provides safety and peace of mind.
Babysense is clinically proven and medically certified. It is approved to the Medical Devices Directive 93/42/ EEC and is listed as Medical Device in Europe, Israel, Australia, Japan, Korea, Canada, etc.


Objectives: Penetrating Babysense product to the Target Countries.
Target businesses: Distributors, Manufacturers, Investors, Strategic Partners.
Target Countries: Germany, UK, France, Italy, Spain, Benelux, Denmark, Sweden, Austria, Romania, Bulgaria, Baltic countries, Russia, CIS countries, India, Singapore, S. Korea, Malaysia, Thailand, Vietnam, Taiwan, Philippines, Mexico, Brazil, USA, Canada, Turkey, S. Africa.